WASHINGTON, DC—New data from the PARTNER 3 low-risk trial of patients with symptomatic, severe aortic stenosis show that TAVI ...

In the diverse cohort, risks were particularly amplified in Black Americans, likely due to structural and environmental factors.

Diastolic BP was higher years after giving birth for women who reported stress—but only if they’d had a complicated pregnancy ...

Women had better self-care at 5 years with self-expanding valves, raising questions about lower gradients and stroke impacts.

Ami Bhatt discusses the effort to build an infrastructure and guardrails for AI and how clinicians can take part.

The study of LAAO cases provides physicians with evidence they can cite when requesting tools for additional protection.

Jonathan Cunningham discusses how AI might help, from patient selection to event adjudication.

Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.

Data are early, retrospective, and unlikely to influence guidelines, but interest among operators is growing, says Sameh Sayfo.

The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most ...

For primary prevention patients at high risk, such as those with a 10-year risk > 10%, the LDL target is less than 70 mg/dL (class 2a recommendation). For this group, treatment begins with a ...

In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.